Increased efficacy and reduced cardiotoxicity of metronomic treatment with cyclophosphamide in rat breast cancer

Valentina K. Todorova, Yihong Kaufmann, Vicki Klimberg

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background/Aim: It has been reported that continuous low-dose (metronomic) administration of cytotoxic drugs may be better tolerated and may have greater antitumor effects than a single high-dose chemotherapy. The aim of this study was to examine the efficacy and cardiotoxicity of metronomic administration of two of the most commonly used anticancer agents, cyclophosphamide (CPA) and doxorubicin (DOX), on an experimental breast cancer of rats. Materials and Methods: Breast tumors were induced in Fisher 344 female rats by implanting Mat B III cells. Rats with tumors were randomized into three groups and were treated with a total dose of 160 mg/kg CPA and a total dose of 12 mg/kg DOX, administered twice per week for four weeks. Control rats were injected with saline according to the same schedule. Echocardiography was performed before the start of treatment and before sacrifice, which took place two weeks after the last injection, when plasma troponin was also measured. Results: The metronomic CPA eradicated the tumors and preserved body weight and echocardiographic parameters. The metronomic DOX slowed tumor growth, but was not able to prevent DOX-induced cardiotoxicity. Conclusion: These results suggest that the success of a metronomic chemotherapy in terms of both efficacy and toxicity depends on the target, the class and the route of administration of the anticancer agent.

Original languageEnglish (US)
Pages (from-to)215-220
Number of pages6
JournalAnticancer Research
Volume31
Issue number1
StatePublished - Jan 2011
Externally publishedYes

Fingerprint

Metronomic Administration
Doxorubicin
Cyclophosphamide
Breast Neoplasms
Antineoplastic Agents
Drug Therapy
Neoplasms
Troponin
Therapeutics
Echocardiography
Appointments and Schedules
Body Weight
Injections
Cardiotoxicity
Growth

Keywords

  • Breast cancer
  • Cardiotoxicity
  • Cyclophosphamide
  • Doxorubicin
  • Metronomic
  • Rats

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Increased efficacy and reduced cardiotoxicity of metronomic treatment with cyclophosphamide in rat breast cancer. / Todorova, Valentina K.; Kaufmann, Yihong; Klimberg, Vicki.

In: Anticancer Research, Vol. 31, No. 1, 01.2011, p. 215-220.

Research output: Contribution to journalArticle

@article{cb90f3f77f92416eb5a7ea6956ee5cf1,
title = "Increased efficacy and reduced cardiotoxicity of metronomic treatment with cyclophosphamide in rat breast cancer",
abstract = "Background/Aim: It has been reported that continuous low-dose (metronomic) administration of cytotoxic drugs may be better tolerated and may have greater antitumor effects than a single high-dose chemotherapy. The aim of this study was to examine the efficacy and cardiotoxicity of metronomic administration of two of the most commonly used anticancer agents, cyclophosphamide (CPA) and doxorubicin (DOX), on an experimental breast cancer of rats. Materials and Methods: Breast tumors were induced in Fisher 344 female rats by implanting Mat B III cells. Rats with tumors were randomized into three groups and were treated with a total dose of 160 mg/kg CPA and a total dose of 12 mg/kg DOX, administered twice per week for four weeks. Control rats were injected with saline according to the same schedule. Echocardiography was performed before the start of treatment and before sacrifice, which took place two weeks after the last injection, when plasma troponin was also measured. Results: The metronomic CPA eradicated the tumors and preserved body weight and echocardiographic parameters. The metronomic DOX slowed tumor growth, but was not able to prevent DOX-induced cardiotoxicity. Conclusion: These results suggest that the success of a metronomic chemotherapy in terms of both efficacy and toxicity depends on the target, the class and the route of administration of the anticancer agent.",
keywords = "Breast cancer, Cardiotoxicity, Cyclophosphamide, Doxorubicin, Metronomic, Rats",
author = "Todorova, {Valentina K.} and Yihong Kaufmann and Vicki Klimberg",
year = "2011",
month = "1",
language = "English (US)",
volume = "31",
pages = "215--220",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Increased efficacy and reduced cardiotoxicity of metronomic treatment with cyclophosphamide in rat breast cancer

AU - Todorova, Valentina K.

AU - Kaufmann, Yihong

AU - Klimberg, Vicki

PY - 2011/1

Y1 - 2011/1

N2 - Background/Aim: It has been reported that continuous low-dose (metronomic) administration of cytotoxic drugs may be better tolerated and may have greater antitumor effects than a single high-dose chemotherapy. The aim of this study was to examine the efficacy and cardiotoxicity of metronomic administration of two of the most commonly used anticancer agents, cyclophosphamide (CPA) and doxorubicin (DOX), on an experimental breast cancer of rats. Materials and Methods: Breast tumors were induced in Fisher 344 female rats by implanting Mat B III cells. Rats with tumors were randomized into three groups and were treated with a total dose of 160 mg/kg CPA and a total dose of 12 mg/kg DOX, administered twice per week for four weeks. Control rats were injected with saline according to the same schedule. Echocardiography was performed before the start of treatment and before sacrifice, which took place two weeks after the last injection, when plasma troponin was also measured. Results: The metronomic CPA eradicated the tumors and preserved body weight and echocardiographic parameters. The metronomic DOX slowed tumor growth, but was not able to prevent DOX-induced cardiotoxicity. Conclusion: These results suggest that the success of a metronomic chemotherapy in terms of both efficacy and toxicity depends on the target, the class and the route of administration of the anticancer agent.

AB - Background/Aim: It has been reported that continuous low-dose (metronomic) administration of cytotoxic drugs may be better tolerated and may have greater antitumor effects than a single high-dose chemotherapy. The aim of this study was to examine the efficacy and cardiotoxicity of metronomic administration of two of the most commonly used anticancer agents, cyclophosphamide (CPA) and doxorubicin (DOX), on an experimental breast cancer of rats. Materials and Methods: Breast tumors were induced in Fisher 344 female rats by implanting Mat B III cells. Rats with tumors were randomized into three groups and were treated with a total dose of 160 mg/kg CPA and a total dose of 12 mg/kg DOX, administered twice per week for four weeks. Control rats were injected with saline according to the same schedule. Echocardiography was performed before the start of treatment and before sacrifice, which took place two weeks after the last injection, when plasma troponin was also measured. Results: The metronomic CPA eradicated the tumors and preserved body weight and echocardiographic parameters. The metronomic DOX slowed tumor growth, but was not able to prevent DOX-induced cardiotoxicity. Conclusion: These results suggest that the success of a metronomic chemotherapy in terms of both efficacy and toxicity depends on the target, the class and the route of administration of the anticancer agent.

KW - Breast cancer

KW - Cardiotoxicity

KW - Cyclophosphamide

KW - Doxorubicin

KW - Metronomic

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=79851479070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79851479070&partnerID=8YFLogxK

M3 - Article

C2 - 21273601

AN - SCOPUS:79851479070

VL - 31

SP - 215

EP - 220

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1

ER -